DrsGunawardenaTerlevich Ltd 12242826 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is general medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true 12242826 2024-04-01 2025-03-31 12242826 2025-03-31 12242826 core:RetainedEarningsAccumulatedLosses 2025-03-31 12242826 core:ShareCapital 2025-03-31 12242826 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 12242826 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 12242826 bus:SmallEntities 2024-04-01 2025-03-31 12242826 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 12242826 bus:FullAccounts 2024-04-01 2025-03-31 12242826 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 12242826 bus:RegisteredOffice 2024-04-01 2025-03-31 12242826 bus:Director1 2024-04-01 2025-03-31 12242826 bus:Director2 2024-04-01 2025-03-31 12242826 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12242826 core:FurnitureFittings 2024-04-01 2025-03-31 12242826 core:MotorVehicles 2024-04-01 2025-03-31 12242826 core:OfficeEquipment 2024-04-01 2025-03-31 12242826 countries:England 2024-04-01 2025-03-31 12242826 2024-03-31 12242826 2023-04-01 2024-03-31 12242826 2024-03-31 12242826 core:RetainedEarningsAccumulatedLosses 2024-03-31 12242826 core:ShareCapital 2024-03-31 12242826 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 12242826 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 iso4217:GBP xbrli:pure

Registration number: 12242826

DrsGunawardenaTerlevich Ltd

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2025

 

DrsGunawardenaTerlevich Ltd

Contents

Abridged Balance Sheet

1 to 2

Notes to the Unaudited Abridged Financial Statements

3 to 5

 

DrsGunawardenaTerlevich Ltd

(Registration number: 12242826)
Abridged Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

38,562

49,856

Current assets

 

Cash at bank and in hand

 

31,369

33,907

Creditors: Amounts falling due within one year

(12,131)

(11,219)

Net current assets

 

19,238

22,688

Total assets less current liabilities

 

57,800

72,544

Creditors: Amounts falling due after more than one year

(33,637)

(41,241)

Net assets

 

24,163

31,303

Capital and reserves

 

Called up share capital

100

100

Profit and loss account

24,063

31,203

Total equity

 

24,163

31,303

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

 

DrsGunawardenaTerlevich Ltd

(Registration number: 12242826)
Abridged Balance Sheet as at 31 March 2025

Approved and authorised by the Board on 13 October 2025 and signed on its behalf by:
 


Dr H Gunawardena

Director


Dr A Terlevich

Director

 

DrsGunawardenaTerlevich Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU

These financial statements were authorised for issue by the Board on 13 October 2025.

2

Accounting policies

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

 

DrsGunawardenaTerlevich Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Included within the fixed assets are assets purchased under a hire purchase agreemenrt with a net book value of £34,617 (2024 £46,156).

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures and fittings

33% straight line

Motor Vehicles

20% straight line

Office equipment

33% straight line

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2024 - 2).

 

DrsGunawardenaTerlevich Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

4

Tangible assets

Total
£

Cost or valuation

At 1 April 2024

65,869

Additions

3,204

At 31 March 2025

69,073

Depreciation

At 1 April 2024

16,013

Charge for the year

14,498

At 31 March 2025

30,511

Carrying amount

At 31 March 2025

38,562

At 31 March 2024

49,856